Literature DB >> 10670924

Preparation and biodistribution of rhenium-188 labeled albumin microspheres B 20: a promising new agent for radiotherapy.

G Wunderlich1, J Pinkert, M Andreeff, M Stintz, F F Knapp, J Kropp, W G Franke.   

Abstract

Intra-arterial infusion of labeled particles is an effective method for endoradiotherapy of tumors. In this study, we radiolabeled biodegradable HSA microspheres (mean diameter = 25 microm) with the short-lived beta-emitter 188Re available from the aluminia-based 188W/188Re generator system. After 1 h 35-40% of the relative large amount of Sn(II) chloride required for effective reduction of Re(VII) for efficient attachment to the particles is precipitated as an amorphous coat of tin hydroxid colloid on the particle surface. The final 188Re bound to the particles was found to be stable in vitro. The radiolabelling yield was > 90%. The biological half-life was > 250 h and demonstrated sufficient in vivo stability after i.v. injection in Wistar rats. Because of the attractive properties of 188Re and the uniform particle size and stability, in vivo, this new agent is an attractive candidate for endoradiotherapy of tumors after selective catheterization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10670924     DOI: 10.1016/s0969-8043(99)00093-7

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  8 in total

Review 1.  Pharmaceutical strategies utilizing recombinant human serum albumin.

Authors:  Victor Tuan Giam Chuang; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

2.  Albumin microspheres as carriers for the antiarthritic drug celecoxib.

Authors:  Hetal Thakkar; Rakesh Kumar Sharma; Anil Kumar Mishra; Krishna Chuttani; Rayasa Ramchandra Murthy
Journal:  AAPS PharmSciTech       Date:  2005-09-20       Impact factor: 3.246

3.  Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18.

Authors:  Chao Lou; Zhi-Nan Chen; Hui-Jie Bian; Jie Li; Shou-Bo Zhou
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 4.  Transarterial Radioembolization Agents: a Review of the Radionuclide Agents and the Carriers.

Authors:  Aysheh Alrfooh; Aditi Patel; Sandeep Laroia
Journal:  Nucl Med Mol Imaging       Date:  2021-07-13

5.  Rhenium-188 production in hospitals, by w-188/re-188 generator, for easy use in radionuclide therapy.

Authors:  Maria Argyrou; Alexia Valassi; Maria Andreou; Maria Lyra
Journal:  Int J Mol Imaging       Date:  2013-04-09

6.  188Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates.

Authors:  Eduardo Savio; María Cristina Ures; Patricia Zeledón; Victoria Trindade; Andrea Paolino; Virginia Mockford; Antonio Malanga; Marcelo Fernández; Javier Gaudiano
Journal:  BMC Nucl Med       Date:  2004-01-30

7.  Initial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers.

Authors:  Mirosław L Nowicki; Jarosław B Cwikla; Artur J Sankowski; Sergey Shcherbinin; Josh Grimmes; Anna Celler; John R Buscombe; Andrzej Bator; Maciej Pech; Renata Mikołajczak; Dariusz Pawlak
Journal:  Med Sci Monit       Date:  2014-08-02

Review 8.  Transarterial Radioembolization (TARE) Agents beyond 90Y-Microspheres.

Authors:  C Bouvry; X Palard; J Edeline; V Ardisson; P Loyer; E Garin; N Lepareur
Journal:  Biomed Res Int       Date:  2018-12-31       Impact factor: 3.246

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.